Crossmark

Combination of sofosbuvir, pegylated-interferon and ribavirin for treatment of hepatitis C virus genotype 1 infection: a systematic review and meta-analysis

Crossref DOI link: https://doi.org/10.1186/s40199-017-0177-x

Published Online: 2017-04-20

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dolatimehr, Fardin

Karimi-Sari, Hamidreza

Rezaee-Zavareh, Mohammad Saeid

Alavian, Seyed Moayed

Behnava, Bita

Gholami-Fesharaki, Mohammad

Sharafi, Heidar
License Information

Text and Data Mining valid from 2017-04-20
More Information

Article History

Received: 26 November 2016

Accepted: 11 April 2017

First Online: 20 April 2017

Document is current

Any future updates will be listed below